Key facts
- RedDrop Dx’s last known valuation is $6.0M (Sep 2022).
- It has raised $9.8M; the latest was Seed Round ($7.0M) in Dec 2025.
- Notable investors include Innosphere Ventures, Stout Street Capital, Breakthrough Venture Capital, Colorado BioScience Association, Innosphere Ventures Fund — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for RedDrop Dx
- ·The full record, as it builds
Funding rounds
No funding rounds for RedDrop Dx are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About RedDrop Dx
Developer of a device designed to allow blood collection to be done quickly, painlessly, and without a trained professional. The company's product offers a pain-free, low-cost, easy-to-use, whole blood and plasma collection and dispensing system, enabling patients to have a device that is self-operated and collects the amount of blood required for biologically relevant tests.
- Sector
- Healthcare
- HQ
- Fort Collins, CO, United States
- Founded
- 2019
- Employees
- 10
- Website
- reddropdx.com/
- Ownership
- Privately Held (backing)
RedDrop Dx doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in RedDrop Dx shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on RedDrop Dx in its N-PORT filings yet. We sweep new filings monthly.